About JSR Life Sciences
Learn what we are all about
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers.
JSR supports the drug discovery and development needs of our partners with tailored solutions that identifies and applies the right tools and technologies to support their unique therapeutic programs. From de-risking molecule selection and accelerating biologic development timelines, to increasing clinical success rates and developing in vitro diagnostics, JSR Life Sciences is committed to guiding our customers’ innovative science along the path to becoming life-saving medicines.
Accelerating Our Life Sciences Footprint
We offer our partners best-in-class research products and services for outsourced drug discovery and development. With our proprietary products and services and through our affiliate companies, JSR has a global presence including 28 sites in seven countries.
Our Affiliates
We leverage the core competencies of our affiliates to create integrated solutions that are designed to guide our partners’ programs from the lab through commercialization.
Crown Bioscience
Contract research organization with advanced technology for precision medicine
Similis Bio
Similis Bio jump-starts your biosimilar program with pre-qualified analytical methods, detailed reference product characterization & off-the-shelf assets.
MBL
Biomarker discovery for companion and in vitro diagnostics
KBI Biopharma
Global contract development and manufacturing organization with advanced analytical capabilities
JSR’s specialty life science research products include:
Amsphere A3, a protein A chromatography resin for advanced protein separation
Magnosphere hydrophilic and hydrophobic microparticles for research and in vitro diagnostics use
JSR Life Sciences is a business unit of JSR Corporation, a multinational advanced materials and solutions company based in Japan.
Latest JSR Life Sciences news
「MEBGEN™ BRAF 2 キット」製造販売承認取得のお知らせ
このたびの製造販売承認取得により、本試薬が、根治切除不能な甲状腺がんの患者に対しBRAF遺伝子変異の有無に応じた個別化医療の迅速な提供に貢献すると期待されます。当社では今後、本試薬の保険適用に係る手続きを進めてまいります。
JSR Active Innovation Fund合同会社が AI医療機器を開発・販売するアイリス株式会社に出資
JSR-AIFは、デジタル技術を中心とするスタートアップへの投資をグローバルに行っており、今回の出資は、アイリス社のAI（人工知能）医療機器の研究開発および、販売営業、マーケティング促進のための資金調達を目的とした第三者割当による新株式発行の引受となります。
第一種医療機器製造販売業許可取得のお知らせ
このたびの第一種医療機器製造販売業許可取得により、次世代シーケンサ―（NGS）を用いた遺伝子検査システムをはじめとした高度管理医療機器の製造販売に対応できるようになります。これを皮切りに、今後さらなる先進的・革新的な検査を開発し人々の健康と医療の発展に貢献できるよう邁進してまいります。